.svg){kind=small}
Mar-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the competitive cannabis market of California, Breez has shown a consistent performance in the Capsules category, maintaining the second rank from December 2023 through March 2024. This consistency is underlined by their sales, which, despite a slight decrease from December 2023's $1,722,644 to February 2024's $1,624,408, saw a rebound in March 2024 to $1,678,627. However, their journey in the Edible category tells a different story. Breez struggled to maintain a strong position, fluctuating outside the top 30 brands from December 2023 to March 2024, with a noticeable decline in sales and ranking, dropping to the 37th position by March 2024. This indicates a potential area for improvement or a shift in consumer preferences within the Edible sector.
Furthermore, Breez's venture into the Tincture & Sublingual and Topical categories in California showcases varied outcomes. The brand experienced a gradual decline in the Tincture & Sublingual category, moving from the 11th rank in December 2023 to the 15th by March 2024. This descent is paralleled by a significant decrease in sales over the same period, hinting at either increased competition or decreased market share. Interestingly, Breez's presence in the Topical category was short-lived, with a ranking in December 2023 but no subsequent rankings or sales data available. This absence might suggest a strategic withdrawal or a need to reassess their approach in this category. Overall, Breez's performance across different categories in California presents a mixed bag of steadfast dominance, challenges, and potential pivots in strategy.
Competitive Landscape
In the competitive landscape of the cannabis capsule market in California, Breez has maintained a strong position, consistently ranking 2nd from December 2023 through March 2024. Despite facing stiff competition, Breez's sales have shown resilience, with a slight dip in January and February 2024 before rebounding in March. The brand's main competitor, Level, has held the top spot throughout the same period, with sales that are notably higher, indicating a significant lead in the market. Meanwhile, ABX / AbsoluteXtracts and Kikoko have been vying for positions just below Breez, with Kikoko showing an upward trend, moving from 5th to 3rd place, potentially challenging Breez's position in the future. This dynamic suggests that while Breez has a solid foothold in the market, emerging trends and shifts among competitors could impact its rank and sales, underscoring the importance of continuous innovation and marketing strategies to maintain its competitive edge.
Notable Products
In March 2024, Breez's top-selling product was the Indica Extra Strength Tablet 50-Pack (1000mg) within the Capsules category, maintaining its number one rank from previous months with sales figures reaching 10,590 units. Following closely, the Sativa Extra Strength Tablet 50-Pack (1000mg) and the Hybrid Extra-Strength Tablet 50-Pack (1000mg) held their second and third positions, respectively, showcasing consistent consumer preference within the Capsules category. The Sativa Royal Mint 20-Pack (100mg) from the Edible category also retained its fourth position, indicating a stable demand among edible consumers. A newcomer in the top rankings for March, the CBD/THC/CBN 2:1:1 Nighttime Extra Strength Tablets 50-Pack (500mg CBD, 250mg THC, 250mg CBN), landed in the fifth position, highlighting a growing interest in products with a diverse cannabinoid profile. This analysis reveals a strong consumer loyalty towards Breez's Capsules, with a notable interest in their new cannabinoid-balanced offerings.
Top Selling Cannabis Brands
